FRT · NYSE · STOCK
Federal Realty Investment Trust (FRT) Stock Analysis
$106.24
52W $90.03 – $128.21
52/100
$9.17B
21.2
0.94
Is FRT Bullish or Bearish?
Mixed.
Innellis AI committee rates Federal Realty Investment Trust (FRT) Watch with a composite score of 52/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +8.26 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -11.74 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 1.53) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Dividend yield of 4.7% pays you to wait — Value
- 3 consecutive earnings beats -- consistent execution — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Debt-to-equity of 1.53 adds balance-sheet risk to the value case — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
- Weekly RSI at 20 -- oversold on the larger timeframe too — Technical
- High leverage (debt-to-equity 1.53) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
52/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 66%
of 80 Real Estate peers
Value Analyst
neutral
50
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 4.7% pays you to wait
− Debt-to-equity of 1.53 adds balance-sheet risk to the value case
Growth Analyst
neutral
52
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 3 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
54
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
30
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 1.53) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
60
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 50.5 to 51.7.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
Analyst-level changes:
- Technical Analyst: score 46->54 (+8); +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
30.2
Neutral
MACD Histogram
-0.128
Bearish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$102.50
Resistance
$107.47
Bollinger %B
0.22
Inside Bands
Price vs Moving Averages
EMA 9
$106.92
Below
EMA 21
$109.36
Below
EMA 50
$113.20
Below
EMA 200
$112.52
Below
Fundamental Analysis
Valuation
85
Growth
44
Profitability
73
Financial Health
54
Cash Flow
70
Valuation
P/E Ratio
21.2×
P/B Ratio
2.72×
PEG Ratio
0.78
Dividend Yield
4.29%
52W High
$128.21
52W Low
$90.03
Quality & Growth
ROE
1265.3%
ROA
450.2%
Gross Margin
5404.9%
Operating Margin
3448.6%
Revenue Growth YoY
—
Debt / Equity
1.44
AI Fundamental Assessment
P/E ratio of 21.2 (inexpensive relative to a 15-40x range); Price-to-book of 2.7x; PEG ratio of 0.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 12.7%; Return on assets of 4.5%; Net margin of 32.7%; Gross margin of 54.0%; Current ratio of 1.47 (tight short-term liquidity); Debt-to-equity of 1.44; Free cash flow per share is positive (6.52); Most recent quarter beat estimates by 34.9%; 3 consecutive earnings beats; EPS growth decelerating (+16.0% -> -46.4% QoQ); Average YoY EPS growth of -45.5%; Analyst estimates falling over recent quarters
Get the Full FRT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →